Ovalo, Bimbo M.
HRN: 07-67-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/30/2024
01/06/2025
IV
600 Mg
Q6
Psoas Abscess
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes